BackHorizon Space Acquisition II Overview

Horizon Space Acquisition II EBIT

Horizon Space Acquisition II's EBIT is $-1.1M, below the Healthcare sector average of $130B.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$364.91K
↓ 43.96% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

-$1.07M

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Horizon Space Acquisition II (HSPT) FAQ

Horizon Space Acquisition II's ebit stands at $-1.1M as of March 2026. That is below the Healthcare sector average of $130B. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Horizon Space Acquisition II sits lower the Healthcare benchmark ($130B) with a EBIT of $-1.1M. That is roughly 100.0% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Open the history chart to see whether Horizon Space Acquisition II's EBIT is expanding or contracting. Sustained growth in EBIT can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Horizon Space Acquisition II's EBIT evolved across reporting periods, while the comparison chart places HSPT next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, EBIT is commonly used to spot outliers. Horizon Space Acquisition II's reading of $-1.1M (sector avg $130B) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.